Skip to main content
. Author manuscript; available in PMC: 2022 Aug 16.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2019 Dec 13;153:102041. doi: 10.1016/j.plefa.2019.102041

Table 5.

Risk of spontaneous preterm birth according to concentrations of oxylipins & precursor fatty acids (n =48 including 12 cases of spontaneous preterm birth (25 %)).

Week 14 (n = 48) Week 24 (n = 48)
Below Above Odds p-value Below Above Odds p-value
Median Median Ratio Median Median Ratio

Omega-6 fatty acids and oxylipins
LA** 17% 35% 2.8 .14 21% 30% 1.7 .43
9-HODE 39% 14% 0.2 .05 22% 26% 1.2 .75
13-HODE 26% 26% 1.0 .98 29% 21% 0.6 .49
9,10-DiHOME 25% 25% 1.0 .99 24% 26% 1.1 .87
13H-9,10E-LA 16% 28% 2.0 .41 27% 23% 0.8 .70
9H-12,13E-LA 25% 26% 1.1 .92 24% 19% 0.7 .62
9,12,13-TriHOME 17% 33% 2.5 .18 24% 25% 1.1 .93
GLA 17% 35% 2.8 .14 21% 30% 1.7 .44
DGLA 33% 17% 0.4 .20 29% 22% 0.7 .64
AA 24% 27% 1.2 .79 12% 39% 5.1 .038
5-HETE 8% 42% 8.2 .014 21% 29% 1.6 .49
12-HETE 21% 29% 1.6 .50 21% 29% 1.6 .50
15-HETE 12% 38% 4.4 .050 17% 33% 2.7 .16
TxB2 13% 32% 3.7 .10 25% 25% 1.0 .97
DTA 29% 22% 0.7 .53 29% 22% 0.7 .58
DPA n-6 25% 26% 1.1 .94 25% 26% 1.1 .91
Omega-3 fatty acids and oxylipins
ALA 17% 35% 2.9 .13 17% 35% 2.8 .15
SDA (18:4 n-3) 15% 38% 3.6 .07 25% 26% 1.1 .93
ETA (20:4 n-3) 29% 22% 0.6 .51 25% 26% 1.0 .94
EPA 21% 30% 1.7 .46 25% 26% 1.1 .93
DPA n-3 25% 26% 1.0 .99 21% 30% 1.7 .45
DHA 25% 26% 1.1 .91 21% 30% 1.7 .42
4-HDHA 8% 42% 8.0 .015 25% 26% 1.1 .91
10-HDHA 17% 33% 2.6 .17 22% 30% 1.6 .48
14-HDHA 17% 33% 2.8 .15 25% 25% 1.0 .98
17-HDHA 18% 36% 2.8 .15 18% 33% 2.3 .24
19,20-EpDPA 12% 39% 4.8 .041 17% 35% 2.6 .16
Other
Mead 21% 30% 1.7 .45 25% 26% 1.1 .87
*

Each compound was dichotomized according to median split at each timepoint. Odds ratios and p-values were from logistic regressions adjusted for age and parity.Due to the selection process for inclusion in this substudy, the overall risk of preterm birth is 25%.

**

9,10-EpOME & 9,10,13-TriHOME had >50% values below LOQ. Concentrations: fatty acids (ug/mL); oxylipins (ng/mL).